definiens: shall mean a product that contains an Aptamer, other than an Excluded Aptamer, with Anti - FibrinActivity, and that has, as another component, a nucleic acid that has Anti - Fibrin Antidote Activity, wherein thediscovery, development, manufacture, use, sale or importation of such product would infringe a Valid Claim withinthe Licensed Patent Rights but for the grant and continuing validity of the license granted by [COMPANY] to Regado inSection 2.1 hereof . In addition, if Regado manufactures, uses, sells, offers for sale, has sold or imports a product thatwould constitute a Licensed Product but for the fact that Regado did not discover or develop the Aptamer containedwithin such product, then, that product shall be deemed to be within the definition of the term forall purposes hereunder . For avoidance of doubt, in addition to the foregoing requirements, a product must havetherapeutically significant levels of both Anti - Fibrin Activity and Anti - Fibrin Antidote Activity in order to be a 1.19 shall mean ( a ) those certain patent applications and patents listed on Schedule Ahereto and any patent or patent application claiming priority therefrom ; ( b ) all patents that have issued or in the futureissue from such patent applications, including utility, model and design patents and certificates of invention ; and(c ) all divisionals, continuations, continuations - in - part, reissues, renewals, extensions or foreign counterparts oradditions to any such patent applications and patents